back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-03-23 16:26 Tx date 2023-03-17 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+197 vol |
38,894 | |
| Filed 2023-03-23 16:24 Tx date 2023-03-17 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-480 vol |
1,654 | |
| Filed 2023-03-14 13:08 Tx date 2023-02-21 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+56 vol |
38,697 | |
| Filed 2023-03-14 13:06 Tx date 2023-02-21 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-134 vol |
2,134 | |
| Filed 2023-03-13 19:29 Tx date 2022-06-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$828.00
+138 vol $6.00 each |
||
| Filed 2023-03-13 16:52 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
37 - Stock split or consolidation
|
-44,160 vol |
1,840 | |
| Filed 2022-07-18 12:27 Tx date 2022-06-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$828.00
+138 vol $6.00 each |
||
| Filed 2022-06-10 14:36 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
37 - Stock split or consolidation
|
-44,161 vol |
||
| Filed 2022-06-10 13:51 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
37 - Stock split or consolidation
|
-44,160 vol |
||
| Filed 2023-01-13 13:05 Tx date 2022-11-30 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+115,000 vol $0.03 each |
12,268,800 | |
| Filed 2022-11-30 15:41 Tx date 2022-11-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+115,000 vol $0.03 each |
||
| Filed 2022-11-30 15:42 Tx date 2022-11-30 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,400
+285,000 vol $0.04 each |
12,553,800 | |
| Filed 2022-11-30 15:41 Tx date 2022-11-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+115,000 vol $0.03 each |
12,268,800 | |
| Filed 2022-08-19 17:13 Tx date 2022-08-19 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$76,301
+10,000 vol $7.63 each |
38,779 | |
| Filed 2022-07-22 18:39 Tx date 2022-07-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,846
+1,645 vol $5.99 each |
28,779 | |
| Filed 2022-07-20 15:11 Tx date 2022-07-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+100,000 vol $0.075 each |
12,153,800 | |
| Filed 2022-07-19 14:48 Tx date 2022-07-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80.00
+1,000 vol $0.08 each |
12,053,800 | |
| Filed 2022-07-19 14:48 Tx date 2022-07-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,930
+99,000 vol $0.07 each |
12,052,800 | |
| Filed 2022-07-18 12:27 Tx date 2022-06-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$828.00
+138 vol $6.00 each |
20,945 | |
| Filed 2022-07-18 11:55 Tx date 2022-07-14 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,579
+2,300 vol $5.90 each |
26,996 | |
| Filed 2022-07-18 11:54 Tx date 2022-07-13 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,597
+2,280 vol $5.96 each |
24,696 | |
| Filed 2022-07-07 12:21 Tx date 2022-07-05 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,554
+1,271 vol $5.94 each |
22,416 | |
| Filed 2022-07-04 00:15 Tx date 2022-06-30 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,028
+338 vol $6.00 each |
21,145 | |
| Filed 2022-06-23 17:00 Tx date 2022-06-23 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,668
+3,778 vol $6.00 each |
20,807 | |
| Filed 2022-06-23 12:58 Tx date 2022-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+134 vol |
17,029 | |
| Filed 2022-06-23 12:58 Tx date 2022-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-134 vol |
2,267 | |
| Filed 2022-06-23 12:54 Tx date 2022-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,033
+2,743 vol $5.85 each |
16,895 | |
| Filed 2022-06-10 14:36 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
37 - Stock split or consolidation
|
-44,161 vol |
1,839 | |
| Filed 2022-06-10 14:02 Tx date 2022-06-06 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+188 vol |
14,152 | |
| Filed 2022-06-10 14:01 Tx date 2022-06-06 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-188 vol |
2,401 | |
| Filed 2022-06-10 13:58 Tx date 2022-06-06 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+750 vol |
2,590 | |
| Filed 2022-06-10 13:56 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-105,600 vol |
4,400 | |
| Filed 2022-06-10 13:54 Tx date 2022-06-06 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250 vol |
4,650 | |
| Filed 2022-06-10 13:51 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
37 - Stock split or consolidation
|
-44,160 vol |
||
| Filed 2022-06-10 13:51 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
37 - Stock split or consolidation
|
-44,160 vol |
1,840 | |
| Filed 2022-06-10 13:50 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-66,000 vol |
||
| Filed 2022-06-10 13:48 Tx date 2022-04-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-335,156 vol |
13,964 | |
| Filed 2022-04-25 12:28 Tx date 2021-12-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-84,000
-240,000 vol $0.35 each |
300,000 | |
| Filed 2022-04-01 20:57 Tx date 2022-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
11,953,800 | |
| Filed 2022-03-18 14:33 Tx date 2022-03-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-12,000 vol |
46,000 | |
| Filed 2022-03-18 14:31 Tx date 2022-03-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,000 vol |
349,120 | |
| Filed 2022-03-18 14:30 Tx date 2022-03-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
$-16,560
-12,000 vol $1.38 each |
||
| Filed 2022-02-22 13:43 Tx date 2022-02-20 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,334 vol |
337,120 | |
| Filed 2022-02-22 13:42 Tx date 2022-02-20 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-3,334 vol |
58,000 | |
| Filed 2022-02-22 13:40 Tx date 2021-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-3,333 vol |
61,334 | |
| Filed 2022-02-22 13:36 Tx date 2021-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,333 vol |
133,786 | |
| Filed 2021-12-22 13:37 Tx date 2021-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,065
+3,333 vol $2.42 each |
||
| Filed 2021-12-22 13:35 Tx date 2021-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$8,065
+3,333 vol $2.42 each |
||
| Filed 2021-12-22 13:37 Tx date 2021-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,065
+3,333 vol $2.42 each |
133,786 | |
| Filed 2021-12-22 13:35 Tx date 2021-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$8,065
+3,333 vol $2.42 each |
||
| Filed 2021-12-16 19:38 Tx date 2021-12-15 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+25,000 vol $0.60 each |
145,000 | |
| Filed 2021-12-16 19:34 Tx date 2021-12-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-50,250
-15,000 vol $3.35 each |
110,000 | |
| Filed 2021-12-16 19:32 Tx date 2021-12-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-82,000
-20,000 vol $4.10 each |
125,000 | |
| Filed 2021-12-16 19:25 Tx date 2019-03-26 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,000
+200,000 vol $0.41 each |
310,100 | |
| Filed 2021-12-16 19:04 Tx date 2019-03-26 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,000
+20,000 vol $4.10 each |
||
| Filed 2021-12-16 18:37 Tx date 2021-12-15 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+25,000 vol $0.60 each |
||
| Filed 2021-12-16 18:37 Tx date 2021-12-15 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+25,000 vol $0.60 each |
145,000 | |
| Filed 2019-04-06 00:06 Tx date 2019-03-26 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,000
+200,000 vol $0.41 each |
||
| Filed 2021-10-28 23:55 Tx date 2021-10-28 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$228,000
+80,000 vol $2.85 each |
340,000 | |
| Filed 2021-09-10 12:47 Tx date 2020-10-20 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
260,000 | |
| Filed 2021-09-01 19:08 Tx date 2021-09-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72,500
+500,000 vol $0.145 each |
11,958,800 | |
| Filed 2021-08-19 16:33 Tx date 2021-08-19 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$75,540
+100,000 vol $0.76 each |
330,453 | |
| Filed 2021-07-15 17:54 Tx date 2020-10-20 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$132,300
+70,000 vol $1.89 each |
||
| Filed 2021-07-15 17:46 Tx date 2020-06-29 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Holder: Northview Ventures & Associates GP. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
38,317 | ||
| Filed 2021-07-15 17:43 Tx date 2021-03-05 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$109,650
+25,500 vol $4.30 each |
133,333 | |
| Filed 2021-07-15 17:42 Tx date 2021-03-05 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,700
+12,400 vol $4.25 each |
107,833 | |
| Filed 2021-07-15 17:40 Tx date 2021-03-05 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,883
+2,100 vol $4.23 each |
95,433 | |
| Filed 2021-07-15 17:37 Tx date 2021-03-04 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$44,000
+10,000 vol $4.40 each |
93,333 | |
| Filed 2021-03-03 15:25 Tx date 2021-03-03 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$171,240
+40,000 vol $4.28 each |
||
| Filed 2021-03-03 15:24 Tx date 2021-03-02 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$44,000
+10,000 vol $4.40 each |
||
| Filed 2020-10-23 18:10 Tx date 2020-10-20 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$132,300
+70,000 vol $1.89 each |
||
| Filed 2021-06-29 13:41 Tx date 2021-06-29 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93,580
+100,000 vol $0.94 each |
230,453 | |
| Filed 2021-06-22 17:15 Tx date 2021-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$44,893
+51,602 vol $0.87 each |
130,453 | |
| Filed 2021-06-22 17:14 Tx date 2021-06-21 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,106
+48,398 vol $0.87 each |
78,851 | |
| Filed 2021-06-18 16:53 Tx date 2019-06-28 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,095 vol |
120 | |
| Filed 2021-06-18 16:36 Tx date 2020-06-12 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$678.00
+200 vol $3.39 each |
||
| Filed 2021-06-18 16:30 Tx date 2019-06-28 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,093 vol |
||
| Filed 2021-06-18 16:25 Tx date 2018-09-18 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-120,323 vol |
1,215 | |
| Filed 2020-06-15 15:00 Tx date 2020-06-12 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$678.00
+200 vol $3.39 each |
||
| Filed 2021-06-15 17:49 Tx date 2019-06-25 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-280,000 vol |
30,100 | |
| Filed 2021-06-15 17:02 Tx date 2019-06-25 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-180,000 vol |
||
| Filed 2021-06-15 17:00 Tx date 2018-09-18 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-169,900 vol |
10,100 | |
| Filed 2021-06-15 15:08 Tx date 2020-07-06 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-10,100 vol |
489,900 | |
| Filed 2021-06-15 15:07 Tx date 2021-03-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
569,900 | |
| Filed 2021-06-15 15:05 Tx date 2020-10-07 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
509,900 | |
| Filed 2021-06-15 14:17 Tx date 2021-03-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,000 vol |
152,071 | |
| Filed 2021-06-15 14:15 Tx date 2021-02-20 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,333 vol |
140,071 | |
| Filed 2021-06-15 14:11 Tx date 2021-03-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-12,000 vol |
64,667 | |
| Filed 2021-06-15 14:01 Tx date 2021-02-20 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-3,333 vol |
16,667 | |
| Filed 2021-06-15 13:58 Tx date 2021-03-16 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+60,000 vol |
80,000 | |
| Filed 2021-06-15 13:52 Tx date 2020-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+10,000 vol |
20,000 | |
| Filed 2021-06-15 13:50 Tx date 2020-02-20 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Filed 2021-06-15 13:44 Tx date 2005-06-09 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-15 13:42 Tx date 2020-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
$24,200
+10,000 vol $2.42 each |
||
| Filed 2020-06-24 16:03 Tx date 2020-06-22 |
$NVCN
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
$24,200
+10,000 vol $2.42 each |
||
| Filed 2021-06-02 17:03 Tx date 2021-06-02 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,720
+200,000 vol $0.1586 each |
11,458,800 | |
| Filed 2021-04-28 18:17 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,900
+74,500 vol $0.20 each |
11,258,800 | |
| Filed 2021-04-28 18:15 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,055
+184,500 vol $0.19 each |
11,184,300 | |
| Filed 2021-04-28 18:14 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,585
+41,000 vol $0.185 each |
10,999,800 | |
| Filed 2021-04-28 17:58 Tx date 2017-02-25 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-90,000 vol |
0 | |
| Filed 2021-04-28 17:47 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$185.00
+1,000 vol $0.185 each |
||
| Filed 2021-04-28 17:47 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$185.00
+1,000 vol $0.185 each |
10,959,800 | |
| Filed 2021-04-05 17:49 Tx date 2021-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$187,500
+1,562,500 vol $0.12 each |
10,958,800 | |
| Filed 2021-04-05 17:48 Tx date 2021-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-187,500
-1,562,500 vol $0.12 each |
90,000 | |
| Filed 2021-03-03 15:25 Tx date 2021-03-03 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$171,240
+40,000 vol $4.28 each |
133,333 | |
| Filed 2021-03-03 15:24 Tx date 2021-03-02 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$44,000
+10,000 vol $4.40 each |
93,333 | |
| Filed 2021-01-18 13:30 Tx date 2021-01-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,750
+70,000 vol $0.125 each |
9,396,300 | |
| Filed 2021-01-18 13:29 Tx date 2021-01-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,600
+130,000 vol $0.12 each |
9,326,300 | |
| Filed 2021-01-04 13:10 Tx date 2020-12-31 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+100,000 vol $0.11 each |
9,196,300 | |
| Filed 2021-01-04 13:08 Tx date 2020-12-29 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,100
+100,000 vol $0.101 each |
9,096,300 | |
| Filed 2020-12-09 12:22 Tx date 2020-12-08 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,600
+200,000 vol $0.103 each |
8,996,300 | |
| Filed 2020-12-03 12:53 Tx date 2020-12-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,200
+150,000 vol $0.108 each |
8,796,300 | |
| Filed 2020-11-02 13:57 Tx date 2020-10-30 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,687
+21,500 vol $0.125 each |
8,646,300 | |
| Filed 2020-10-23 18:10 Tx date 2020-10-20 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$132,300
+70,000 vol $1.89 each |
260,000 | |
| Filed 2020-10-20 16:12 Tx date 2020-10-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,150
+150,000 vol $0.101 each |
8,624,800 | |
| Filed 2020-08-10 14:52 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$187,500
+1,562,500 vol $0.12 each |
1,652,500 | |
| Filed 2020-08-10 14:45 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,000
+3,125,000 vol $0.08 each |
8,474,800 | |
| Filed 2020-07-27 14:06 Tx date 2020-06-29 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
190,000 | ||
| Filed 2020-07-27 14:06 Tx date 2020-06-29 |
$PINK
Perimeter Medical Imaging AI, Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
83,333 | ||
| Filed 2020-06-24 16:03 Tx date 2020-06-22 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
$24,200
+10,000 vol $2.42 each |
510,000 | |
| Filed 2020-06-24 15:57 Tx date 2020-06-22 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,100
+5,000 vol $2.42 each |
500,000 | |
| Filed 2020-06-15 15:07 Tx date 2020-06-12 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,560
+13,400 vol $3.40 each |
136,738 | |
| Filed 2020-06-15 15:04 Tx date 2020-06-12 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,695
+500 vol $3.39 each |
123,338 | |
| Filed 2020-06-15 15:02 Tx date 2020-06-12 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,380
+1,000 vol $3.38 each |
122,838 | |
| Filed 2020-06-15 15:00 Tx date 2020-06-12 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$678.00
+200 vol $3.39 each |
121,838 | |
| Filed 2020-06-15 14:59 Tx date 2020-06-12 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$336.00
+100 vol $3.36 each |
121,638 | |
| Filed 2020-06-10 11:46 Tx date 2020-06-09 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,910
+46,000 vol $0.085 each |
5,349,800 | |
| Filed 2020-06-10 11:44 Tx date 2020-06-09 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,320
+54,000 vol $0.08 each |
5,303,800 | |
| Filed 2020-06-10 11:43 Tx date 2020-06-08 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+100,000 vol $0.08 each |
5,249,800 | |
| Filed 2020-01-30 23:46 Tx date 2020-01-27 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
495,000 | |
| Filed 2019-04-06 00:06 Tx date 2019-03-26 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,000
+200,000 vol $0.41 each |
480,000 | |
| Filed 2018-10-02 Tx date 2018-09-28 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$272,000
+100,000 vol $2.72 each |
280,000 | |
| Filed 2018-08-17 Tx date 2018-08-15 |
$
BioHEP Technologies Ltd. |
JANZEN, DOUG
4 - Director of Issuer
Holder: Northview Ventures and Associates GP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
117,500 | ||
| Filed 2018-05-02 Tx date 2017-11-30 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-40,000 vol |
175,000 | |
| Filed 2018-05-02 Tx date 2017-11-30 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-65,000 vol |
215,000 | |
| Filed 2018-05-02 Tx date 2018-02-27 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-65,000 vol |
180,000 | |
| Filed 2018-02-05 Tx date 2018-01-24 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
350,000 | |
| Filed 2017-12-12 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
540,000 | |
| Filed 2017-09-21 Tx date 2017-09-18 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,040
+19,000 vol $0.16 each |
5,149,800 | |
| Filed 2017-09-21 Tx date 2017-09-18 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,770
+281,000 vol $0.17 each |
5,130,800 | |
| Filed 2017-09-13 Tx date 2017-09-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,125
+25,000 vol $0.165 each |
4,849,800 | |
| Filed 2017-08-02 Tx date 2017-07-28 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,255
+11,000 vol $0.205 each |
4,824,800 | |
| Filed 2017-07-14 Tx date 2017-07-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+15,000 vol $0.23 each |
4,803,800 | |
| Filed 2017-07-14 Tx date 2017-07-14 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,250
+10,000 vol $0.225 each |
4,813,800 | |
| Filed 2017-06-21 Tx date 2017-06-16 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,327
+9,500 vol $0.245 each |
4,775,800 | |
| Filed 2017-06-21 Tx date 2017-06-16 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,120
+25,500 vol $0.24 each |
4,766,300 | |
| Filed 2017-06-21 Tx date 2017-06-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,120
+13,000 vol $0.24 each |
4,788,800 | |
| Filed 2017-05-10 Tx date 2016-12-21 |
$LNB
Lexington Biosciences, Inc. (formerly, Glenwood Acquisitions Corp.) |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-10 Tx date 2017-05-09 |
$LNB
Lexington Biosciences, Inc. (formerly, Glenwood Acquisitions Corp.) |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$54,000
+270,000 vol $0.20 each |
270,000 | |
| Filed 2017-05-05 Tx date 2017-05-05 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,500
+50,000 vol $0.25 each |
4,740,800 | |
| Filed 2017-05-05 Tx date 2017-05-03 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,465
+45,500 vol $0.23 each |
4,690,800 | |
| Filed 2017-04-19 Tx date 2017-03-31 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
280,000 | |
| Filed 2016-10-21 Tx date 2016-10-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,160
+6,000 vol $0.36 each |
4,645,300 | |
| Filed 2016-09-26 Tx date 2016-09-23 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,385
+9,000 vol $0.265 each |
4,639,300 | |
| Filed 2016-09-26 Tx date 2016-09-23 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+21,000 vol $0.25 each |
4,630,300 | |
| Filed 2016-09-19 Tx date 2016-09-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,610
+9,000 vol $0.29 each |
4,609,300 | |
| Filed 2016-09-19 Tx date 2016-09-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$285.00
+1,000 vol $0.285 each |
4,600,300 | |
| Filed 2016-09-13 Tx date 2016-09-13 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$249,090
+830,300 vol $0.30 each |
4,599,300 | |
| Filed 2016-06-16 Tx date 2016-06-16 |
$
BioHEP Technologies Ltd. |
JANZEN, DOUG
4 - Director of Issuer
Holder: RBC Dominion Securities Inc ITF Northview LifeSciences and Associates General Partnership (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-16 Tx date 2016-06-16 |
$
BioHEP Technologies Ltd. |
JANZEN, DOUG
4 - Director of Issuer
Holder: Northview LifeSciences and Associates General Partnership (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
235,009 | ||
| Filed 2016-03-31 Tx date 2016-03-28 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,350
+5,000 vol $0.47 each |
3,769,000 | |
| Filed 2016-03-09 Tx date 2015-12-14 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-65,000
-65,000 vol $1.00 each |
250,000 | |
| Filed 2016-03-09 Tx date 2015-12-14 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$65,000
+65,000 vol $1.00 each |
||
| Filed 2016-03-09 Tx date 2015-12-14 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$65,000
+65,000 vol $1.00 each |
||
| Filed 2016-03-09 Tx date 2015-12-14 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$65,000
+65,000 vol $1.00 each |
121,538 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+6,000 vol $0.50 each |
3,764,000 | |
| Filed 2016-02-18 Tx date 2016-02-18 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,850
+10,000 vol $0.485 each |
3,758,000 | |
| Filed 2016-02-18 Tx date 2016-02-16 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,880
+12,000 vol $0.49 each |
3,748,000 | |
| Filed 2015-12-18 Tx date 2015-12-14 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$65,000
+65,000 vol $1.00 each |
380,000 | |
| Filed 2015-12-18 Tx date 2015-12-14 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$65,000
+65,000 vol $1.00 each |
||
| Filed 2015-11-30 Tx date 2015-11-25 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-654.00
-100 vol $6.54 each |
56,638 | |
| Filed 2015-11-30 Tx date 2015-11-25 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-653.00
-100 vol $6.53 each |
56,738 | |
| Filed 2015-11-30 Tx date 2015-11-25 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-652.00
-100 vol $6.52 each |
56,838 | |
| Filed 2015-11-30 Tx date 2015-11-25 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-192,400
-29,600 vol $6.50 each |
56,938 | |
| Filed 2015-11-30 Tx date 2015-11-25 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-96,750
-15,000 vol $6.45 each |
86,538 | |
| Filed 2015-11-30 Tx date 2015-11-25 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$96,750
+15,000 vol $6.45 each |
||
| Filed 2015-11-30 Tx date 2015-11-26 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$610.00
+1,000 vol $0.61 each |
3,736,000 | |
| Filed 2015-11-30 Tx date 2015-11-25 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,360
+6,000 vol $0.56 each |
3,735,000 | |
| Filed 2015-11-30 Tx date 2015-11-25 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-655.00
-100 vol $6.55 each |
56,538 | |
| Filed 2015-11-23 Tx date 2015-11-19 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,225
-500 vol $6.45 each |
101,538 | |
| Filed 2015-11-23 Tx date 2015-11-18 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-34,830
-5,400 vol $6.45 each |
102,038 | |
| Filed 2015-11-23 Tx date 2015-11-16 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,805
-900 vol $6.45 each |
107,438 | |
| Filed 2015-11-23 Tx date 2015-11-23 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,600
+5,000 vol $0.52 each |
3,729,000 | |
| Filed 2015-11-17 Tx date 2015-11-13 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+10,000 vol $0.50 each |
3,724,000 | |
| Filed 2015-11-17 Tx date 2015-11-13 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
70 - Acquisition or disposition (writing) of third party derivative
|
$3,640
+7,000 vol $0.52 each |
3,714,000 | |
| Filed 2015-11-17 Tx date 2015-11-11 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+10,000 vol $0.50 each |
3,707,000 | |
| Filed 2015-11-17 Tx date 2015-11-11 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,350
+5,000 vol $0.47 each |
3,697,000 | |
| Filed 2015-11-06 Tx date 2015-11-04 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,020
+2,000 vol $0.51 each |
3,692,000 | |
| Filed 2015-11-06 Tx date 2015-11-04 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+5,000 vol $50.00 each |
3,690,000 | |
| Filed 2015-11-06 Tx date 2015-11-03 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+5,000 vol $50.00 each |
3,685,000 | |
| Filed 2015-11-06 Tx date 2015-11-02 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,160
+8,000 vol $0.52 each |
3,680,000 | |
| Filed 2015-09-08 Tx date 2015-09-03 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,200
+4,000 vol $0.55 each |
3,672,000 | |
| Filed 2015-08-24 Tx date 2015-08-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,860
+3,000 vol $0.62 each |
3,668,000 | |
| Filed 2015-08-16 Tx date 2015-08-13 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,900
+5,000 vol $0.58 each |
3,665,000 | |
| Filed 2015-08-16 Tx date 2015-08-11 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,850
+7,000 vol $0.55 each |
3,660,000 | |
| Filed 2015-07-17 Tx date 2015-07-14 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,240
+3,500 vol $0.64 each |
3,647,000 | |
| Filed 2015-07-17 Tx date 2015-07-14 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$945.00
+1,500 vol $0.63 each |
3,643,500 | |
| Filed 2015-07-17 Tx date 2015-07-16 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,080
+6,000 vol $0.68 each |
3,653,000 | |
| Filed 2015-06-18 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,080
+2,000 vol $0.54 each |
3,642,000 | |
| Filed 2015-06-18 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,640
+7,000 vol $0.52 each |
3,640,000 | |
| Filed 2015-06-12 Tx date 2015-06-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+1,500 vol $0.60 each |
3,633,000 | |
| Filed 2015-06-12 Tx date 2015-06-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,994
+3,500 vol $0.57 each |
3,631,500 | |
| Filed 2015-06-12 Tx date 2015-06-10 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+2,000 vol $0.60 each |
3,628,000 | |
| Filed 2015-06-12 Tx date 2015-06-10 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,770
+3,000 vol $0.59 each |
3,626,000 | |
| Filed 2015-06-12 Tx date 2015-06-09 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,950
+5,000 vol $0.59 each |
3,623,000 | |
| Filed 2015-06-09 Tx date 2015-06-08 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,720
+6,000 vol $0.62 each |
3,618,000 | |
| Filed 2015-06-09 Tx date 2015-06-03 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,490
+9,000 vol $0.61 each |
3,612,000 | |
| Filed 2015-05-27 Tx date 2015-05-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,840
+6,000 vol $0.64 each |
3,603,000 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,200
+5,000 vol $0.64 each |
3,597,000 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,260
+2,000 vol $0.63 each |
3,592,000 | |
| Filed 2015-05-22 Tx date 2015-05-21 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,880
+8,000 vol $0.61 each |
3,590,000 | |
| Filed 2015-05-22 Tx date 2015-05-21 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,180
+2,000 vol $0.59 each |
3,582,000 | |
| Filed 2015-05-19 Tx date 2015-05-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+10,000 vol $0.65 each |
3,580,000 | |
| Filed 2015-05-19 Tx date 2015-05-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+10,000 vol $0.60 each |
3,570,000 | |
| Filed 2015-05-14 Tx date 2015-05-13 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-223,925
-26,500 vol $8.45 each |
108,338 | |
| Filed 2015-05-14 Tx date 2015-05-13 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-126,000
-15,000 vol $8.40 each |
134,838 | |
| Filed 2015-05-14 Tx date 2015-05-13 |
$NVC
Neovasc Inc. |
JANZEN, DOUG
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-82,500
-10,000 vol $8.25 each |
149,838 | |
| Filed 2015-05-14 Tx date 2015-05-14 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+10,000 vol $0.60 each |
3,560,000 | |
| Filed 2015-04-30 Tx date 2015-04-30 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+15,000 vol $0.60 each |
3,550,000 | |
| Filed 2015-04-30 Tx date 2015-04-29 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+35,000 vol $0.60 each |
3,535,000 |